Cargando…
Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions
Long-term follow-up data comparing surgical and endovascular revascularization of femoropopliteal lesions is rarely reported. This study presents 4-year results of revascularization for long femoropopliteal lesions (Trans-Atlantic Inter-Society Consensus Types C and D) with vein bypass (VBP), polyte...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219229/ https://www.ncbi.nlm.nih.gov/pubmed/37240613 http://dx.doi.org/10.3390/jcm12103507 |
_version_ | 1785048959740280832 |
---|---|
author | Kluckner, Michaela Gruber, Leonhard Wippel, David Lobenwein, Daniela Westreicher, Werner Pilz, Manuela Enzmann, Florian K. |
author_facet | Kluckner, Michaela Gruber, Leonhard Wippel, David Lobenwein, Daniela Westreicher, Werner Pilz, Manuela Enzmann, Florian K. |
author_sort | Kluckner, Michaela |
collection | PubMed |
description | Long-term follow-up data comparing surgical and endovascular revascularization of femoropopliteal lesions is rarely reported. This study presents 4-year results of revascularization for long femoropopliteal lesions (Trans-Atlantic Inter-Society Consensus Types C and D) with vein bypass (VBP), polytetrafluorethylene bypass (PTFE), and endovascular intervention with a nitinol stent (NS). Data from a randomized-controlled trial on VBP and NS was compared with a retrospective patient cohort using PTFE with the same inclusion and exclusion criteria. Primary, primary assisted, and secondary patency, as well as changes in Rutherford categories and limb salvage rates, are reported. Between 2016 and 2020, 332 femoropopliteal lesions underwent revascularization. The lesion lengths and basic patient characteristics were similar between the groups. 49% of the patients presented with chronic limb threatening ischemia at the time of revascularization. During the four-year follow-up, primary patency was comparable for all three groups. Primary assisted and secondary patency were significantly higher after VBP, while PTFE and NS had similar results. Clinical improvement was also significantly superior after VBP. After four years of follow-up, patency rates as well as the clinical outcome clearly favor VBP. If no vein is available, NS is as effective as PTFE bypass with regard to patency and clinical outcome. |
format | Online Article Text |
id | pubmed-10219229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102192292023-05-27 Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions Kluckner, Michaela Gruber, Leonhard Wippel, David Lobenwein, Daniela Westreicher, Werner Pilz, Manuela Enzmann, Florian K. J Clin Med Article Long-term follow-up data comparing surgical and endovascular revascularization of femoropopliteal lesions is rarely reported. This study presents 4-year results of revascularization for long femoropopliteal lesions (Trans-Atlantic Inter-Society Consensus Types C and D) with vein bypass (VBP), polytetrafluorethylene bypass (PTFE), and endovascular intervention with a nitinol stent (NS). Data from a randomized-controlled trial on VBP and NS was compared with a retrospective patient cohort using PTFE with the same inclusion and exclusion criteria. Primary, primary assisted, and secondary patency, as well as changes in Rutherford categories and limb salvage rates, are reported. Between 2016 and 2020, 332 femoropopliteal lesions underwent revascularization. The lesion lengths and basic patient characteristics were similar between the groups. 49% of the patients presented with chronic limb threatening ischemia at the time of revascularization. During the four-year follow-up, primary patency was comparable for all three groups. Primary assisted and secondary patency were significantly higher after VBP, while PTFE and NS had similar results. Clinical improvement was also significantly superior after VBP. After four years of follow-up, patency rates as well as the clinical outcome clearly favor VBP. If no vein is available, NS is as effective as PTFE bypass with regard to patency and clinical outcome. MDPI 2023-05-17 /pmc/articles/PMC10219229/ /pubmed/37240613 http://dx.doi.org/10.3390/jcm12103507 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kluckner, Michaela Gruber, Leonhard Wippel, David Lobenwein, Daniela Westreicher, Werner Pilz, Manuela Enzmann, Florian K. Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title | Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title_full | Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title_fullStr | Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title_full_unstemmed | Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title_short | Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions |
title_sort | long-term outcome of bypass surgery versus endovascular revascularization in long femoropopliteal lesions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219229/ https://www.ncbi.nlm.nih.gov/pubmed/37240613 http://dx.doi.org/10.3390/jcm12103507 |
work_keys_str_mv | AT klucknermichaela longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT gruberleonhard longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT wippeldavid longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT lobenweindaniela longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT westreicherwerner longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT pilzmanuela longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions AT enzmannfloriank longtermoutcomeofbypasssurgeryversusendovascularrevascularizationinlongfemoropopliteallesions |